Answers are grounded in this paper and cite their sources.
Sex differences in morbidity and mortality have been reported in the cystic fibrosis (CF) population worldwide. However, it is unclear why CF women have worse clinical outcomes than men. In this review, we focus on the influence of female sex hormones on CF pulmonary outcomes and summarise data from in vitro and in vivo experiments on how oestrogen and progesterone might modify mucociliary clearance, immunity and infection in the CF airways. The potential for novel sex hormone-related therapeutic interventions is also discussed.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: